Advertisement

Inpharma Weekly

, Volume 1248, Issue 1, pp 16–16 | Cite as

Docetaxel is active in patients with unresectable metastatic or locally advanced pancreatic cancer,

Clinical study
  • 3 Downloads

Keywords

Adenocarcinoma Pancreatic Cancer Neutropenia Docetaxel Partial Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2000

Personalised recommendations